Policy / Pricing Decoding Medicare Advantage Coding Intensity KFF MedicareFederal payments to Medicare Advantage plans, and adjustments for health status, have come under increased scrutiny.Read full story pharminent July 1, 2026 (Last updated: July 2, 2026) KFF Medicare Federal payments to Medicare Advantage plans, and adjustments for health status, have come under increased scrutiny. Read full story Post navigation Previous: Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M dealNext: Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026